According to Sino Biotech's announcement, Rao Jin, the company's deputy general manager and secretary of the board of directors, originally planned to increase his holdings of the company from June 9 to December 8, 2026. The proposed increase in holdings was not less than 8 million yuan and no more than 10 million yuan. As of November 6, 2026, Rao Jin has yet to increase his holdings in the company, and the plan to increase his holdings has not been completed. In the future, he will continue to increase his holdings according to the plan during the implementation period. The current increase in holdings may not be implemented as expected due to factors such as changes in the capital market, and there is uncertainty.

According to Sino Biotech's announcement, Rao Jin, the company's deputy general manager and secretary of the board of directors, originally planned to increase his holdings of the company from June 9 to December 8, 2026. The proposed increase in holdings was not less than 8 million yuan and no more than 10 million yuan. As of November 6, 2026, Rao Jin has yet to increase his holdings in the company, and the plan to increase his holdings has not been completed. In the future, he will continue to increase his holdings according to the plan during the implementation period. The current increase in holdings may not be implemented as expected due to factors such as changes in the capital market, and there is uncertainty.